Препарати, які модифікують структуру остеоартрозу: огляд наукової літератури

Основний зміст сторінки статті

В. М. Левенець
В. В. Манжалій

Анотація

Проведен анализ препаратов гиалуроновой кислоты, которые могут модифицировать течение остеоартроза у спортсменов. Высказано предположение, что препарат, в частности Синокром, влияет на патологические процессы, связанные с симптомами остеоартроза. Вискосапплементация завоевывает все большую популярность в качестве консервативного лечения у спортсменов. В случае остеоартроза у спортсменов выявлено уменьшение концентрации молекул гиалуроновой кислоты и снижение вязкости синовиальной жидкости. Вискосапплементация может стимулировать производство эндогенной гиалуроновой кислоты, которая положительно влияет на суставной хрящ путем эндопротекторного механизма. Это особенно важно для спортсменов на фоне постоянных больших нагрузок и возможности ежегодных повторений без побочных действий.

Блок інформації про статтю

Номер
Розділ
Статті

Посилання

Levenets V. М. Sports traumatology / V. М. Levenets, Y. V. Linko. – Кyiv: Оlimpiiska literatura, 2008. – 245 p.

Levenets V. N. Peculiarities of diagnosis and complex therapy of athletes at pre-arthrosis stage / V. N. Levenets, М. М. Rigan, I. М. Тyutyunnik // Sport. med. – 2013. – N1 – P. 33–47.

Коvalenko V. N. Оsteoarthrosis: practical guide / V. N. Коvalenko, О. P. Bortkevich. – Кiev: Моrion, 2003. – 147 p.

Adams M. E. Hypertrophic repair of canine articular cartilage in osteoarthritis after anterior cruciate ligament transaction / M. E. Adams, K. D. Brandt // Rheumat. – 1991. – Vol. 18(3).– P. 428–435.

Altman R. D. Double-blind randomired trial of intra- articular injection of sodium hyalunane (Hyalgan) for the treatment of chrome shoulder pain / R. D. Altman, R. Moskowitz, S. Iacobs et. al. // Arthritis Rheumatal. – 2005. Vol. 5/2 (suppl. I). – P. 54. 6. Altman R. D. Efficacy of intra-articular hyaluronan (Hyalgan) in a double-blind study for osteoarthritis of the ankle / R. D. Altman, M. M. Cohem, R. Iollstrom et. al. // Osteoarthritis Cartilage. –2006. – V. 14 (suppl. B). – S. 170.

Bagga H. Long-term effects of osteoarthritis / H. Bagga, D. Burkhardt, P. Sambrook et al. // Clin. Exp. Rheumat. – 2005. – V. 23(5). – P. 711–716.

Balazs F. A. Viscosupplementation: a new concept in the treatment of osteoarthritis /F. A. Balazs, I. L. Denlinger // I. Rheumat. Suppl. – 1993. – Vol. 39. – P. 3–9.

Bellamy N. Viscosupplementation for the treatment of osteoarthritis of the knee / N. Bellamy et al//Cochrane Data- base Syst. Rev. – 2006. – CD005321.

Brockmeier S. F. Visco-supplemention therapy for osteoarthritis / S. F. Brockmeir, B. S. Shaffer // Sports Med. Arthroscop – 2006. – Vol. 14(3). – P. 155–162.

Bulstra S. K. The effecting vitro of irrigating solutions on intact rat articular cartilage /S. K. Bulstra. R Kuijer, P. Eerdmans et al. // I. Bone Ioint Surg. Br. – 1994. – Vol. 76(3). – P. 468–470.

Clark S. Intraarticular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee / S. Clark, V. Lock, I. Dunddy et al. // POAK-Knee. – 2005. Vol. 12(1). – P. 57–62.

Dahlberg L. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain: one year double-blind, placebo-controlled study / L. Dahlberg, L. S. Lohmander, L. Ryd // Arthrits Rheumat. –1994. – Vol. 37(4).– P. 521–528.

Diaz-Gallego L. Apopto-sisand nitric oxide in an experimental in model of osteoarthritis in rabbit after hyaluronic acid treatment / L.Diaz-Gallego et al. // I. Orthop. Res. – 2006. – Vol. 23(6). – P. 1370–1376.

Divine I. G. Viscosupplementation for knee osteo­ arthritis: a systematic review / I. G. Divine, B. T. Zazulak, T. E. Hewett // Clin. Orthop. Relat Res. – 2007. – Vol. 455. – P. 113–122.

Echigo R. Suppressive effect of hyaluronan on chond­ rocyte apoptosis in experimentally induced acute osteoarthritis in dogs / R. Echigo, M. Mochizuki, R. Nisihmura et al. // Med. Sci. – 2005. – Vol. 68(8). – P. 899–902.

Ghosh P. The role of hyaluronic acid (hyaluronans in health and disease: interactions with cells, cartilage and components of synovial fluid / P. Ghosh // Clin. Exp. Rheu­ mat. – 1994. – Vol. 12(1). – P. 75–82.

Goldberg V. M. Pseudoseptic reactions to hylan visco­ supplementation: diagnosis and treatment / V. M. Goldberg, R. D. Coutts // Clin Orthop. Relares. – 2004. – Vol. 419. – P. 130–137.

Goldberg V. M. Hyaluronans in the treatment of osteo­ arthritis of the knee: evidence for disease-modifying activity / V. M. Goldberg, I. A. Buckwalter // Osteoarthritis Cartilage. – 2005. – Vol. 13(3). – P. 216–224.

Hempfling H. Intra-articular hyaluronic acid after knee arthroscopy: a two-year study / H. Hempfling // Knee Surg Sports Trdumatol Arthrosc. – 2007. – Vol. 15(5). – P. 537– 546.

Hootman J. M. Projections of prevalence of arthritis and associated activity limitations / J. M. Hootman, C. G. Helmick // Arthritis Rheumat. – 2006. – Vol. 54(1). – P. 226–229.

Kirwan I. Is there a place for intra-articular hyalunate in osteoarthritis of the knee? / I. Kirwan // The knee. – 2001. – Vol. 8. – P. 93–101.

Kotevoglu N. A prospective-randomized controlled clinical trial comparing the efficiency of different molecular weight hyaluronan solutions / N. A. Kotevoglu et al. // Rheumat Int. – 2006. – Vol. 26. – P. 325–330.

Migliore A. The sympionatic effents of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up / A. Migliore, S. Tormenta, L. Martin et al. //Clin Rheumat. – 2006. – Vol. 25(3). – P. 389–393.

Miyakoshi N. Effects of intra-articular administration of basic fibroblast growth factor with hyaluronic acid on osteochondral defects of the knee in rabbits / N. Miyakoshi et al. //Arch. Orthop. Trauma Surg. – 2005. – Vol. 125(10). – P. 683–692.

Moskowitz R. W. An overview of treatment options for persistent shoulder pain /R. W. Moskowitz, T. A. Blaine// Am. I. Orthop. – 2005. – Vol. 34(12 suppl). – P. 10–15.

Pourbagher M. A. Accuracy and outcome of sono­ graphically guided intra-articular sodium hyaluronate injection in patients with osteoarthritis of the hip / M. A Pourbagher et al.// I. Ultra Sound Med. – 2005. – Vol. 24 (10). – P. 1391– 1395.

Punzi L. The influence of intra-articular hyaluronic acid on P6E2 and c AMP of synovial fluid / L. Punzi et al. // I. Rheumatol. – 1995. – Vol. 22(7). – P. 1311–1314.

Santangelo K. S. Effects of hyaluronan treatment on lopopobysaccharide-challenged fibroblast-like synovial cells / K. S. Santangelo, L. Amanda Johnson, A. S. Ruppert et al.// Arthritis Research Therapy. – 2007. – Vol. 9, N1.

Stewart W. F. Lost productive time and cost due to common pain conditions in the US workforce / W. F. Stewart, Ricci J. A., Chee E. et al. // JAMA. – 2003. – Vol. 290(18). – P. 2443–2454.

Strauss E. I. Hyaluronic Acid Viscosupplementation and osteoarthritis. Current Uses and Future Direction / E. I. Strauss, I. A. Hart, M. D. Miller et al.// Am. I. Sport Med. – 2009. – P. 48–61.

Tikiz C. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis / C.Tikiz, A. Sener et al. // Clin. Rheumat. – 2005. – Vol. 24(3). – P. 244–250.

Tytherleigh-Strong G. Intra-articular hyaluronan follo­ wing autogenous osteochondral grafting of the knee / G. Ty­ therleigh-Strong, M. Hurtig, A. Miniau // Arthroscopy. – 2005. – Vol. 21(8). – P. 999–1005.

Vagishita K. The effect of hyaluronan on tendon healing in rabbits / K. Vagishita et al. // Arthroscopy. – 2005. – Vol. 21(11). – P. 1330–1336.

Watterson I. R. Viscosupplementation: therapeutic 35. mechanisms and clinical potential in osteoarthritis of the knee / I. R. Watterson, M. Esdail // J. Am. Acad Orhop. Surg. – 2000. – Vol. 8 (5). – P. 277–284.